obesity, orlistat, liraglutide, semaglutide, naltrexone-bupropion, metabolic surgery, bariatric surgery, gastric banding, RYGBP, sleeve gastrectomy, network meta-analysis
acquired resistance, platinum-based chemotherapy, CTLA-4 inhibitors, immunotherapy, non-small cell lung cancer
Immunotherapy, duration, survival, solid tumors
Head and neck cancer, Chemotherapy, Radiotherapy, Treatment-related death